Dr. Christopher Lievens, OD

NPI: 1912990086
Total Payments
$669,855
2024 Payments
$101,404
Companies
30
Transactions
1,230
Medicare Patients
12
Medicare Billing
$454.48

Payment Breakdown by Category

Consulting$357,583 (53.4%)
Other$181,840 (27.1%)
Travel$99,112 (14.8%)
Food & Beverage$31,321 (4.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $357,583 195 53.4%
Travel and Lodging $99,112 534 14.8%
Compensation for serving as faculty or as a speaker for a medical education program $96,363 29 14.4%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $82,358 39 12.3%
Food and Beverage $31,321 430 4.7%
Honoraria $3,040 2 0.5%
Entertainment $80.00 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Alcon Vision LLC $219,332 357 $0 (2024)
Alcon Laboratories Inc $186,729 374 $0 (2018)
Bausch & Lomb Americas Inc. $110,609 160 $0 (2024)
ABBVIE INC. $66,182 127 $0 (2024)
Allergan, Inc. $57,427 119 $0 (2022)
Alcon Research LLC $11,758 14 $0 (2019)
Thea Pharma Inc. $4,719 7 $0 (2024)
Johnson & Johnson Vision Care, Inc. $3,329 15 $0 (2024)
Nidek Incorporated $2,000 1 $0 (2017)
Tarsus Pharmaceuticals, Inc. $1,796 7 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $101,404 180 Bausch & Lomb Americas Inc. ($88,369)
2023 $37,072 60 Bausch & Lomb Americas Inc. ($22,240)
2022 $79,481 152 ABBVIE INC. ($48,790)
2021 $113,531 167 Alcon Vision LLC ($90,231)
2020 $49,851 61 Alcon Vision LLC ($42,987)
2019 $86,118 207 Alcon Vision LLC ($85,273)
2018 $131,970 268 Alcon Laboratories Inc ($131,578)
2017 $70,427 135 Alcon Laboratories Inc ($55,152)

All Payment Transactions

1,230 individual payment records from CMS Open Payments — Page 1 of 50

Date Company Product Nature Form Amount Type
12/31/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $4,800.00 General
Category: Ophthalmology
12/20/2024 Bausch & Lomb Americas Inc. XIPERE (Drug) Food and Beverage In-kind items and services $28.12 General
Category: Ophthalmology
12/17/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $2,400.00 General
Category: Ophthalmology
12/16/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $1,575.00 General
12/12/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Travel and Lodging Cash or cash equivalent $578.96 General
Category: Ophthalmology
12/12/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Travel and Lodging Cash or cash equivalent $241.17 General
Category: Ophthalmology
12/12/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Travel and Lodging Cash or cash equivalent $223.80 General
Category: Ophthalmology
12/12/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $94.58 General
Category: Ophthalmology
12/12/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Travel and Lodging Cash or cash equivalent $34.84 General
Category: Ophthalmology
12/12/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $32.75 General
Category: Ophthalmology
12/06/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $41.03 General
Category: Ophthalmology
12/05/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $90.83 General
Category: Ophthalmology
12/05/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $25.00 General
Category: Ophthalmology
12/05/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Travel and Lodging Cash or cash equivalent $22.78 General
Category: Ophthalmology
11/26/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $4,800.00 General
Category: Ophthalmology
11/26/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $2,400.00 General
Category: Ophthalmology
11/26/2024 Thea Pharma Inc. IYUZEH (Drug) Consulting Fee Cash or cash equivalent $2,000.00 General
Category: OPHTHALMOLOGY
11/22/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $1,575.00 General
11/22/2024 Bausch & Lomb Americas Inc. XIIDRA (Drug), MIEBO Food and Beverage In-kind items and services $44.03 General
Category: Ophthalmology
11/19/2024 Bausch & Lomb Americas Inc. MIEBO (Drug) Food and Beverage In-kind items and services $34.98 General
Category: Ophthalmology
11/14/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Travel and Lodging Cash or cash equivalent $269.34 General
Category: Ophthalmology
11/14/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $125.00 General
Category: Ophthalmology
11/14/2024 Bausch & Lomb Americas Inc. MIEBO (Drug) Food and Beverage In-kind items and services $34.83 General
Category: Ophthalmology
11/14/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $17.24 General
Category: Ophthalmology
11/14/2024 Bausch & Lomb Americas Inc. MIEBO (Drug) Food and Beverage In-kind items and services $13.56 General
Category: Ophthalmology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2020 1 12 12 $1,140 $454.48
Total Patients
12
Total Services
12
Medicare Billing
$454.48
Procedure Codes
1

All Medicare Procedures & Services

1 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
92014 Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits Office 2020 12 12 $1,140 $454.48 39.9%

About Dr. Christopher Lievens, OD

Dr. Christopher Lievens, OD is a Optometrist healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912990086.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Lievens, OD has received a total of $669,855 in payments from pharmaceutical and medical device companies, with $101,404 received in 2024. These payments were reported across 1,230 transactions from 30 companies. The most common payment nature is "Consulting Fee" ($357,583).

As a Medicare-enrolled provider, Lievens has provided services to 12 Medicare beneficiaries, totaling 12 services with total Medicare billing of $454.48. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.

Practice Information

  • Specialty Optometrist
  • Location Memphis, TN
  • Active Since 08/24/2005
  • Last Updated 03/07/2023
  • Taxonomy Code 152W00000X
  • Entity Type Individual
  • NPI Number 1912990086

Products in Payments

  • DAILIES (Device) $238,721
  • MIEBO (Drug) $102,217
  • VUITY (Drug) $99,461
  • ILUX (Device) $46,377
  • Precision 1 (Device) $29,254
  • AIR OPTIX (Device) $8,256
  • DAILIES TOTAL1 (Device) $7,576
  • Clear Care (Device) $6,600
  • TOTAL30 (Device) $6,385
  • IYUZEH (Drug) $3,719
  • TEPEZZA (Drug) $1,421
  • TEARCARE SYSTEM (Device) $1,141
  • Systane (Drug) $1,060
  • XIIDRA (Drug) $937.53
  • LUMIGAN (Drug) $883.18
  • BLINK NUTRITEARS (Drug) $600.00
  • Spectralis (Device) $546.06
  • ALPHAGAN P (Drug) $277.76
  • Contact Lens (Device) $243.75
  • RESTASIS MULTIDOSE (Drug) $227.16

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Optometrist Doctors in Memphis